Pembrolizumab API is a humanized monoclonal antibody against PD-1 used as an immune checkpoint inhibitor in the treatment of multiple advanced cancers.

Pembrolizumab API is manufactured and supplied by ARTIS BIOTECH | ASTANDARDS, ensuring high purity, consistent quality, and regulatory-compliant specifications. Our APIs are produced using validated processes and are suitable for research, development, and pharmaceutical manufacturing applications.